OncologyOptical Coherence Tomography as an Adjunct to White Light Cystoscopy for Intravesical Real-Time Imaging and Staging of Bladder Cancer
Section snippets
Material and Methods
We performed a retrospective institutional review board–approved review of one surgeon's (SPL's) experience with the use of OCT in providing additional diagnostic information in 32 patients undergoing conventional cystoscopy from December 2005 to April 2007. Indications for cystoscopy under anesthesia included history of bladder cancer (24) with a new visible lesion, initial occurrence of bladder cancer seen on flexible cystoscopy (6), prostate cancer (1), or hematuria without visible lesion
Results
The cohort included 25 men (78%) and 7 women (22%) and ages ranged from 49 to 84 years (mean, 59 years). Most (30 of 32) of these patients had a preoperative diagnosis of bladder cancer or initial occurrence of bladder tumor. OCT delineated all three layers of the bladder wall including mucosa, lamina propria, and muscularis propria. The mucosa generally appeared as a dark, thin, clearly defined layer. The lamina propria gave a bright, distinct signal, whereas muscularis showed a darker,
Discussion
The dichotomy of non–muscle-invasive versus muscle-invasive bladder tumors has significant implications for oncologic management as well as patient outcome. In contrast to tumors involving the lamina propria, muscle-invasive tumors are more highly associated with locally advanced disease and distant spread.7 The distinctive behavior of muscle-invasive lesions emphasizes the critical importance of early, accurate identification and necessity for aggressive intervention.
Transurethral resection
Conclusion
We explored OCT in this study as a tool to enhance clinical staging of bladder tumors. The real-time, high-resolution images captured by OCT provide a glimpse of tissue microstructure in vivo. The advantage of such an image modality is that tissue can be studied without being altered or destroyed as in conventional biopsy. The potential is that areas of suspicion can be inspected with OCT before resection to maximize the information gained from biopsy and minimize unnecessary removal of tissue.
References (15)
- et al.
Accurate pathological staging of urothelial neoplasms requires better cystoscopic sampling
J Urol
(2002) - et al.
Correlation of cystoscopic impression with histologic diagnosis of biopsy specimens of the bladder
Hum Pathol
(2001) - et al.
Optical coherence tomography: an emerging technology for biomedical imaging and optical biopsy
Neoplasia
(2000) - et al.
In vivo optical coherence tomography feasibility for bladder disease
J Urol
(2002) - et al.
High-resolution endoscopic imaging of the GI tract: a comparative study of optical coherence tomography versus high-frequency catheter probe EUS
Gastrointest Endosc
(2001) Infiltrating carcinoma of the bladder: relation of early diagnosis to five-year survival rate after complete extirpation
J Am Med Assoc
(1952)- et al.
Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy
Eur Urol
(2007)
Cited by (109)
Growth of Simulated Tumors Under the Influence of Oxygen Supply
2022, IFAC-PapersOnLineEx-vivo evaluation of miniaturized probes for endoscopic optical coherence tomography in urothelial cancer diagnostics
2022, Annals of Medicine and SurgeryPhase II multi-center trial of optical coherence tomography as an adjunct to white light cystoscopy for intravesical real time imaging and staging of bladder cancer
2021, Urologic Oncology: Seminars and Original InvestigationsDiagnostic accuracy of optical coherence tomography for bladder cancer: A systematic review and meta-analysis
2019, Photodiagnosis and Photodynamic TherapyCitation Excerpt :No threshold effect was suggested, with a Spearman coefficient of 0.06 (P = 0.87). Seven studies [17,20,21,23–26], including a total of 1437 lesions, reported the diagnostic accuracy of optical coherence tomography, used alone, for bladder cancer. Pooled sensitivity and specificity were 87.3% (95% confidence interval: 82.7%–91.1%, I2 = 77.5%) and 73.9% (95% confidence interval: 71.3%–76.4%, I2 = 84.2%), respectively (Table 2).
Recent advances in optical imaging technologies for the detection of bladder cancer
2018, Photodiagnosis and Photodynamic TherapyRecent Technological Advances in Cystoscopy for the Detection of Bladder Cancer
2018, Bladder Cancer
Nancy Tresser is affiliated with Imalux Corporation.